Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Neuroendocrine × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1 Advanced Solid Tumor 1

Interventions

toripalimab 1 PE regimen 1 Fluorouracil 1 EC regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03992911 2019-06-20

Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma

Peking University

Phase 2/3 Unknown

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡